In a clinical study, a single injection of CJC-1295 increased IGF-1 levels by up to 3-fold for 10+ days , all while keeping the GH release in a natural pulsatile rhythm
The role of FGF19 in metabolic regulation: Insights from preclinical models to clinical trials
For chronic weight management, both trizepatide (Zepbound) and semaglutide 2.4 mg (Wegovy) are indicated for adults with a BMI 30 or a BMI 27 with at least one weight-related condition (such as hypertension, dyslipidemia, type 2 diabetes, sleep apnea, or cardiovascular disease)
Early intervention provides the best outcomes before extensive follicular miniaturization occurs
Yeh CW, Tseng LH, Yang CH, Hwang CF
GBD 2016 DALYs and HALE Collaborators